Commentary: COVID-19 in cardiac surgery – we are still learning and have yet to see all possible covid-19 complications
The novel coronavirus outbreak in Wuhan, China, led to over 31 million infected and nearly a million deaths 1,2. Coronavirus Disease 2019 (COVID 19), is characterized by extreme virulence and a complex spectrum of pathologies ranging in severity from mild to multi-organ failure3 and death. Over the...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/14583
- Acceso en línea:
- https://doi.org/10.1016/j.xjtc.2020.10.007
http://hdl.handle.net/20.500.12010/14583
- Palabra clave:
- COVID-19
Cardiac Surgery
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Abierto (Texto Completo)
| Summary: | The novel coronavirus outbreak in Wuhan, China, led to over 31 million infected and nearly a million deaths 1,2. Coronavirus Disease 2019 (COVID 19), is characterized by extreme virulence and a complex spectrum of pathologies ranging in severity from mild to multi-organ failure3 and death. Over the past nine months, our knowledge of the pathophysiology and extrapulmonary manifestations of COVID-19 has grown tremendously. Yet, despite this, we are constantly discovering new manifestations such as the development of a hypercoagulable state4-6 . With an anxious global community focused upon the development of a novel vaccine, it’s easy to overlook that unique and potentially fatal complications are yet to be identified. |
|---|